Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Amiodarone-induced thyrotoxicosis].

Fausto Bogazzi1, Luca Tomisti1, Vitantonio Di Bello2

  • 1Unità di Endocrinologia, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi, Pisa.

Giornale Italiano Di Cardiologia (2006)
|April 12, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addison's disease in Italy: mortality and survival by etiology.

Journal of endocrinological investigation·2026
Same author

Cushing's disease and negative MRI: a single-center series, systematic literature review, and meta-analysis.

Neurosurgical review·2026
Same author

Role of MEN1 mutations on postoperative outcomes of patients with multiple endocrine neoplasia type 1-related primary hyperparathyroidism: a single center experience.

Journal of endocrinological investigation·2025
Same author

Editorial: Crosstalk between thyroid and heart.

Frontiers in endocrinology·2025
Same author

Epidemiology of Thyroid Cancer in Tuscany (Central Italy) 2013-2017: Not Just Overdiagnosis.

Cancers·2025
Same author

Was the painter's model for Hercules an acromegalic giant?

Journal of endocrinological investigation·2024
Same journal

Giornale italiano di cardiologia (2006)·2026
Same journal

[Green paper ANMCO: Environmental sustainability in cardiology: a shared commitment of healthcare professionals].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Ranolazine: established indications and emerging therapeutic potential].

Giornale italiano di cardiologia (2006)·2026
Same journal

[Kawasaki disease: the update of American Heart Association guidelines. What adult cardiologists need to know].

Giornale italiano di cardiologia (2006)·2026
Same journal

[The application of artificial intelligence in arrhythmology].

Giornale italiano di cardiologia (2006)·2026
See all related articles

Amiodarone therapy frequently causes thyroid dysfunction, including hypothyroidism and thyrotoxicosis. Differentiating and treating these conditions, such as amiodarone-induced hypothyroidism (AIH) and amiodarone-induced thyrotoxicosis (AIT), is crucial for patient management.

Area of Science:

  • Endocrinology
  • Cardiology
  • Pharmacology

Background:

  • Amiodarone therapy is associated with a 15-20% incidence of thyroid dysfunction.
  • This dysfunction can manifest as hypothyroidism or thyrotoxicosis.
  • Underlying thyroid conditions can influence the type of amiodarone-induced thyroid dysfunction.

Purpose of the Study:

  • To outline the clinical presentation and management of amiodarone-induced thyroid dysfunction.
  • To differentiate between amiodarone-induced hypothyroidism (AIH) and the two types of amiodarone-induced thyrotoxicosis (AIT 1 and AIT 2).
  • To emphasize the importance of collaborative care between cardiologists and endocrinologists.

Main Methods:

  • Review of clinical presentations and established treatment guidelines for amiodarone-induced thyroid dysfunction.

Related Experiment Videos

  • Classification of AIT into AIT 1 (iodine-induced hyperthyroidism in autonomous thyroid) and AIT 2 (destructive thyroiditis).
  • Discussion of treatment strategies including L-thyroxine, glucocorticoids, thionamides, and thyroidectomy.

    • Main Results:

    • AIH is clinically straightforward and managed with L-thyroxine.
    • AIT 1 responds to thionamides, while AIT 2 is treated with glucocorticoids.
    • Thyroidectomy is reserved for specific indications like cardiac risk or non-response to medical therapy.

    Conclusions:

    • Effective management of amiodarone-induced thyroid dysfunction requires accurate diagnosis and tailored treatment based on the underlying mechanism.
    • Close collaboration between cardiology and endocrinology is essential for optimal patient outcomes.
    • Treatment decisions must consider the patient's cardiac status and the necessity of continuing amiodarone therapy.